4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0001209191-16-142261
$ORKACIK 0000907654operating
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 4:09 PM ET
Size
7.4 KB
Accession
0001209191-16-142261
Insider Transaction Report
Form 4
BRISTOW MICHAEL R
DirectorChief Science and Med. Officer
Transactions
- Sale
Common Stock
2016-09-20$2.89/sh−1,972$5,699→ 42,638 total
Holdings
- 19,986(indirect: By Trust)
Common Stock
- 25,459(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan")
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $2.88 to $2.89. Upon request of the SEC staff, ARCA biopharma, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes (i) remaining 4,050 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning on 2/27/17, and (ii) 4,581 previously reported shares issued as RSUs under the Plan that vest in two equal annual installments beginning 4/2/17, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan; and 34,007 previously reported shares of common stock held directly.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 4:09 PM ET
- Size
- 7.4 KB